https://anticorruptiondigest.com/an...d&utm_medium=twitter&utm_content=anti_digest
"A Conditional Agreement was recently reached between Teva Pharmaceuticals Industries Ltd. (“Company“
and the Israeli State Attorney’s Office, pursuant to which the Company shall pay the State of Israel a fine in the total aggregate amount of NIS 75 million (app. $22 million) due to, and admit to the facts in respect of, the Company’s involvement in a foreign bribery affair in 2012.
The 2012 affair spanned various bribery payments made by the Company via its foreign subsidiaries to public officials in Russian, the Ukraine and Mexico in violation of the FCPA (the Foreign Corrupt Practice Act), which prohibits the bribery of foreign public officials, as well as such other similar and applicable domestic laws in the countries involved (including, inter alia, the Israeli Penal Law). Such bribery payments were written off under the Company’s consolidated financial reports as legitimate business expenses so as to reflect a profit of approximately USD 220 million in the Company’s books, all by way of transfer of payments to foreign public officials prohibited by law. Such actions ultimately led to an investigation conducted by the DOJ and SEC and resulted in a Deferred Prosecution Agreement (“DPA“
reached between the Company and the American law enforcement authorities in December 2016. As part of the DPA the Company agreed to pay a fine of USD 519 million in order to settle the civil and criminal charges brought against it in regards to violations of the FCPA, and it was further concluded that an independent corporate monitor was to be appointed to oversee the implantation of the Company’s compliance program and reform for a period of three years."
Teva just got hit with a big fine.
Teva was in a lawsuit with Apotex.
"And Teva Pharmaceuticals Industries , the world's biggest maker of generic drugs, is currently in a legal dispute with Apotex over allegations a former Teva executive shared trade secrets with Apotex CEO Jeremy Desai.
Teva is also weighed by $35 billion in debt it took on to acquire Allergan's Actavis generic drug business for $40.5 billion last year. Last week it said it would axe 14,000 jobs.
A Teva spokeswoman in Israel had no immediate comment when asked about any takeover plans or the status of its legal case against Apotex"
Follow the money. Who stands to gain from the Shermans death?
Big Pharma takeover.
Billions��